Synergistic Effect of miR-383 and Cisplatin on Inhibition of Growth, Proliferation, and Migration of Lung Cancer Cells
Archives of Iranian Medicine · 2025
DOI: 10.34172/aim.33450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Iranian Medicine, 2025. Verfasst von Vagef Elyaszadeh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Science, Faculty of Basic Science, Higher Education Institute of Rab-Rashid, Tabriz, Iran. Hauptthemen laut MEDLINE: Cisplatin, MicroRNAs, Cell Proliferation, Lung Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Lung cancer (LC) is a common life-threatening malignancy in humans. Cisplatin has been widely used in the treatment of various types of cancer. miR-383 is dysregulated in multiple cancers, and participates in tumorigenic processes, including apoptosis, proliferation, metastasis, and drug resistance. This study aimed to investigate the synergistic effect of miR-383 and cisplatin in LC.
Methods
A549 cells were treated with cisplatin and miR-383 separately or in combination. Cell viability, apoptosis induction, stemness features, migratory capacity, and autophagy were measured by various methods. In addition, quantitative real-time PCR (qRT‐PCR) was used to evaluate the expression levels of genes involved in apoptosis, stemness, and migration.
Results
The results demonstrated that miR-383 transfection in A549 cells increased their chemosensitivity to cisplatin, enhancing cisplatin-induced apoptosis (from 11.28% to 37.86%). This effect was mediated by regulating key genes such as Bcl-2 and Caspase-3 (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Science, Faculty of Basic Science, Higher Education Institute of Rab-Rashid, Tabriz, Iran.
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
ORCID-Profile: Vagef Elyaszadeh, Maryam Tohidast, Seyed Samad Hosseini, Mohammad Amini, Parinaz Marami, Behzad Baradaran, Amir Ali Mokhtarzadeh, Asiyeh Jebelli
Zitieren
APA
Elyaszadeh, V., Tohidast, M., Hosseini, S. S., Amini, M., Marami, P., Baradaran, B., Mokhtarzadeh, A. A., & Jebelli, A. (2025). Synergistic Effect of miR-383 and Cisplatin on Inhibition of Growth, Proliferation, and Migration of Lung Cancer Cells. Archives of Iranian Medicine. https://doi.org/10.34172/aim.33450
Vancouver
Elyaszadeh V, Tohidast M, Hosseini SS, Amini M, Marami P, Baradaran B, et al. Synergistic Effect of miR-383 and Cisplatin on Inhibition of Growth, Proliferation, and Migration of Lung Cancer Cells. Archives of Iranian Medicine. 2025. doi:10.34172/aim.33450
BibTeX
@article{Elyaszadeh2025,
author = {Elyaszadeh, Vagef and Tohidast, Maryam and Hosseini, Seyed Samad and Amini, Mohammad and Marami, Parinaz and Baradaran, Behzad and Mokhtarzadeh, Amir Ali and Jebelli, Asiyeh},
title = {Synergistic Effect of miR-383 and Cisplatin on Inhibition of Growth, Proliferation, and Migration of Lung Cancer Cells},
journal = {Archives of Iranian Medicine},
year = {2025},
doi = {10.34172/aim.33450}
}
EUVIMED